[Streptococcus pneumoniae serotypes in Cuba and progression of resistance to penicillin]

Gilda T Toraño Peraza1, Rafael Llanes Caballero, Lisania M Pías Solis

  • 1Laboratorio Nacional de Referencia para Neumococo, Instituto De Medicina Tropical Pedro Kouri, Ciudad de La Habana, Cuba. gilda@ipk.sld.cu

Abstract

Insights

Active surveillance for Streptococcus pneumoniae (pneumococcus) is crucial in Cuba due to emerging resistant strains and serotypes not covered by current vaccines. Enhanced monitoring is needed before infant vaccination schedules are updated.

Area of Science:

  • Microbiology
  • Epidemiology
  • Vaccinology

Context:

  • Bacterial meningitis and invasive diseases caused by Streptococcus pneumoniae (pneumococcus) are challenging to track in Cuba.
  • Low isolation and identification rates in microbiology labs hinder accurate incidence determination.

Purpose:

  • To highlight the necessity of revitalizing active surveillance for invasive pneumococcal diseases, including meningitis and pneumonia.
  • To inform strategies before the implementation of pneumococcal conjugate vaccines in the infant vaccination schedule.

Summary:

  • A comparative analysis of Streptococcus pneumoniae serogroups/serotypes and penicillin susceptibility was conducted between 1994-2006 and 2007-2009.
  • The study identified the circulation of serogroups not included in current conjugate vaccines (e.g., serogroup 15) and serotypes linked to antimicrobial resistance (e.g., serotype 5).
  • An increase in penicillin resistance among pneumococcal isolates was observed.

Impact:

  • Further studies with a larger number of isolates are required to ensure the effectiveness of Streptococcus pneumoniae conjugate vaccines in Cuba.
  • This research will aid in assessing rising penicillin resistance and developing appropriate therapeutic guidelines for the Cuban context.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...